Author: Thomas Xavier
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.10, Iss.3, 2005-08, pp. : 591-617
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Novel and Emerging Drugs for Acute Lymphoblastic Leukemia
Current Cancer Drug Targets, Vol. 12, Iss. 5, 2012-05 ,pp. :
Emerging drugs for chronic lymphocytic leukaemia
By Yee Karen WL O’Brien Susan M
Expert Opinion on Emerging Drugs, Vol. 11, Iss. 1, 2006-03 ,pp. :
Idarubicin: Acute lymphoblastic leukaemia: case report
Reactions Weekly, Vol. 1, Iss. 1203, 2008-01 ,pp. :
Rituximab: Relapse of acute lymphoblastic leukaemia: case report
Reactions Weekly, Vol. 1, Iss. 1177, 2007-01 ,pp. :